AzTrials
AzTrials

Cardiac ArrestCOPILOT-SimNCT03000829

Code Blue Outcomes & Process Improvement Through Leadership Optimization Using Teleintensivists-Simulation

A study testing Tele-intensivist consultation and Simulated "observation" by ICU physician in people with Cardiac Arrest, run by Intermountain Health Care, Inc. at 7 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This multicenter randomized trial will employ in-situ cardiac arrest simulations ("mock codes") to test whether using telemedicine technology to add an intensive care physician as the "copilot" for cardiac arrest resuscitation teams influences chest compression quality, resuscitation protocol adherence, team function… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Arrest
What is being tested?
Tele-intensivist consultation and Simulated "observation" by ICU physician
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
1,001 participants
Where
7 sitesUnited States
Study dates
Dec 2016to Dec 2018
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Are 18 years of age or older
  • Inclusion criteria (teleintensivist cardiac arrest team copilot):
  • Are 18 years of age or older
  • Are a board-certified or board-eligible critical care physician
  • Provide clinical care through the Intermountain Healthcare Telecritical Care program

Who cannot join

  • Are under 18 years of age
  • Are a member of the study research team

Trial locations and contacts

7 sites in 1 country.

7 sites in 1 country

United States7 sites
  • American Fork Hospital

    American Fork, Utah, 84003

  • Intermountain Medical Center

    Murray, Utah, 84107

  • The Orthopedic Specialty Hospital

    Murray, Utah, 84107

  • McKay-Dee Hospital

    Ogden, Utah, 84403

  • Park City Hospital

    Park City, Utah, 84060

  • Riverton Hospital

    Riverton, Utah, 84065

  • LDS Hospital

    Salt Lake City, Utah, 84143

Other trials in United States

About this study

This multicenter randomized trial will employ in-situ cardiac arrest simulations ("mock codes") to test whether using telemedicine technology to add an intensive care physician as the "copilot" for cardiac arrest resuscitation teams influences chest compression quality, resuscitation protocol adherence, team function, and provider experience.

Read the detailed description

Only 15-30% of patients who suffer in-hospital cardiac arrest (IHCA) survive to hospital discharge. Factors associated with lower mortality and improved function include provision of high-quality, minimally-interrupted chest compressions and swift defibrillation of eligible arrhythmias. Unfortunately, resuscitation teams provide suboptimal care to 25-40% of IHCA victims. A dedicated IHCA team "copilot" may improve resuscitation team performance by providing the team leader with parallel analysis, situational awareness augmentation, action checking, protocol verification, and error correction. Critical care physician involvement via a telemedicine link could allow experienced specialists to fill the "copilot" role in a cost and resource-efficient manner, particularly in smaller hospitals with fewer available physicians.

The current study will evaluate how consultation by an off-site intensive care physician via a telemedicine link influences local IHCA teams' quality of care, team function and provider experience during simulated cardiac arrest events ("mock codes").

Conditions
Cardiac Arrest
Being tested
Tele-intensivist consultation, Simulated "observation" by ICU physician
Keywords
Code blue, Code team, Crisis team leadership, Cardiopulmonary resuscitation, Telemedicine, Simulation, Mock code, In-hospital cardiac arrest
Medical subject headings
Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tele-intensivist consultationOther

    Standardized consultation to on-site cardiac arrest team by off-site intensivist via two-way audiovisual link using a mobile telemedicine cart

  • Simulated "observation" by ICU physicianOther

    Display of silent, pre-recorded, non-interactive videotape of an ICU physician. The on-site cardiac arrest team will be told that an intensive care physician is observing the mock code.

Study groups in NCT03000829
Study groupRoleWhat they receive
Tele-intensivist consultationExperimentalStandardized consultation to on-site cardiac arrest response team by off-site intensivist via two-way audiovisual link using a mobile telemedicine cart
Receives: Other: Tele-intensivist consultation
ControlPlacebo comparatorSimulated "observation" by ICU physician by displaying a silent, pre-recorded, non-interactive videotape of an ICU physician. The on-site participants will be told that an intensive care physician is observing the mock code.
Receives: Other: Simulated "observation" by ICU physician

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fraction of Pulseless Time With no Chest Compressions

    Measured: From initiation of intervention or placebo control until completion of two complete cycles of CPR (an average of 4 minutes)

Secondary outcomes (11)
  1. Time From Onset of Shockable Rhythm to Defibrillation

    Measured: From onset of simulated VF or VT until first defibrillation or end of simulation

  2. Fraction of Chest Compressions With Complete Release

    Measured: From initiation of intervention or placebo control until completion of two complete cycles of CPR (an average of 4 minutes)

  3. Fraction of Chest Compressions at Target Rate

    Measured: From initiation of intervention or placebo control until completion of two complete cycles of CPR (an average of 4 minutes)

  4. Time to First Dose of Epinephrine

    Measured: From initiation of simulation through termination of simulation, an average of 15 minutes

  5. Overall ACLS Protocol Adherence (Using Checklist Adapted From McEvoy ACLS Assessment Tool)

    Measured: From initiation of simulation through termination of simulation, an average of 15 minutes

  6. ACLS Protocol Errors (Using Checklist Adapted From McEvoy ACLS Assessment Tool)

    Measured: From initiation of simulation through termination of simulation, an average of 15 minutes

  7. Team Emergency Assessment Measure Score

    The validated "Team Emergency Assessment Measure (TEAM)" evaluates non-technical performance of the on-site resuscitation team. The score (range 0-4) for each simulation was obtained by averaging the mean score for each of 11 component scores (each component item scored 0-4, with higher values representing better performance).

    Measured: From initiation of simulation through termination of simulation, an average of 15 minutes

  8. Types of Input by Telemedical Intensivist Copilot

    Measured: From initiation of simulation through termination of simulation, an average of 15 minutes

  9. Opinions of Study Subjects About Experience Participating in Simulated Cardiac Arrest, Using a Locally-developed and Validated Survey Instrument

    Measured domains: understanding of telemedicine intensivist copilot's role, beliefs about telemedicine intensivist copilot's ability to integrate with on site team, ability to influence on-site team performance, comfort with telemedicine intensivist copilot's role, and function of telemedicine interface

    Measured: Immediately after simulation

  10. Short-form State-Trait Anxiety Inventory Score

    The short-form State-Trait Anxiety Inventory (STAI) measures acute stress experienced by respondents using 6 questions (scores for each question range from 1 to 4, with higher values indicating more stress). Analyzed respondent-level values use the total score (range 4-24) obtained by summing the score for each of the six questions, with higher values indicating more respondent-reported acute stress.

    Measured: Immediately after simulation

  11. Presence of Telemedicine Audiovisual Connection Problems for Intervention Group Simulation Event

    Measured: From initiation of simulation through termination of simulation, an average of 15 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2016 (estimated)
  2. Study startDec 2016
  3. Primary completionDec 2018
  4. Study completionDec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,001 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03000829
Sponsor's protocol ID
COPILOT-SIMULATION
Other IDs
1050317
Acronym
COPILOT-Sim
Status last verified
Dec 2023
First submitted
14 Sep 2016
Last updated
31 May 2024
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Anonymized data will be available, after relevant IRB approval, by application to the principal investigator and Intermountain Office of Research.

Publications

  • Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.

  • Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992 Sep;31(3):301-6. doi: 10.1111/j.2044-8260.1992.tb00997.x.

    PubMed 1393159
  • McKay A, Walker ST, Brett SJ, Vincent C, Sevdalis N. Team performance in resuscitation teams: comparison and critique of two recently developed scoring tools. Resuscitation. 2012 Dec;83(12):1478-83. doi: 10.1016/j.resuscitation.2012.04.015. Epub 2012 May 3.

    PubMed 22561464
  • Cooper S, Cant R, Porter J, Sellick K, Somers G, Kinsman L, Nestel D. Rating medical emergency teamwork performance: development of the Team Emergency Assessment Measure (TEAM). Resuscitation. 2010 Apr;81(4):446-52. doi: 10.1016/j.resuscitation.2009.11.027. Epub 2010 Feb 1.

    PubMed 20117874
  • Peltan ID, Guidry D, Brown K, Kumar N, Beninati W, Brown SM. Telemedical Intensivist Consultation During In-Hospital Cardiac Arrest Resuscitation: A Simulation-Based, Randomized Controlled Trial. Chest. 2022 Jul;162(1):111-119. doi: 10.1016/j.chest.2022.01.017. Epub 2022 Jan 19.

    PubMed 35063451
  • Silva JAM, Mininel VA, Fernandes Agreli H, Peduzzi M, Harrison R, Xyrichis A. Collective leadership to improve professional practice, healthcare outcomes and staff well-being. Cochrane Database Syst Rev. 2022 Oct 10;10(10):CD013850. doi: 10.1002/14651858.CD013850.pub2.

    PubMed 36214207

Questions about this trial

What is this clinical trial studying?

A study testing Tele-intensivist consultation and Simulated "observation" by ICU physician in people with Cardiac Arrest, run by Intermountain Health Care, Inc. at 7 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 31 May 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fraction of Pulseless Time With no Chest Compressions (time frame: From initiation of intervention or placebo control until completion of two complete cycles of CPR (an average of 4 minutes)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03000829, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 May 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in